Post hoc ICONIC phase 3 data show GLP-1 medications do not affect the efficacy, safety, or pharmacokinetics of icotrokinra in ...

Phase 3 ONWARD3 data demonstrate sustained skin clearance, pruritus relief, and quality of life improvements with ...

BRAVE-AA-PEDS data presented at FC26 show baricitinib maintained significant hair regrowth through 76 weeks in adolescents ...

Creams, sprays and washes that promise relief from genital herpes are easy to order online, but none of them are FDA-approved.

An active acupressure intervention offers clinical benefits for patients with rosacea when combined with pharmacotherapy.

Undeclared pharmacologically active ingredients are detected in one-third of over-the-counter skin products marketed online.

Quadrivalent HPV vaccination before pregnancy is associated with a lower risk for adverse pregnancy outcomes, including preterm birth.

Dermatology Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...

Tralokinumab for AD was associated with sustained improvements in disease severity and no new safety signals at 12 months in a real-life study.

While TB and meningitis are rare among patients receiving systemic psoriasis therapies, IL-17 inhibitors increase the risk for candidiasis.

The lifetime risk for heart failure is increasing, and prevalence is projected to continue accelerating, according to a recent report.

Congenital TORCH infections appear to be associated with an increased risk for intellectual disability and autism.